Gene · 5009
Papers3,886
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,886
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetic counselors' perspectives on genomic screening of apparently healthy newborns in the United States. | Genet Med Open | 2024 | 39669612 | PubTator, text mining | PubMed |
| PEG-BCT-100 and Canavanine Synergistically Induce Apoptosis in Arginine Biosynthetic Enzyme-Deficient Pancreatic Cancer. | Cancer Res Commun | 2024 | 39570001 | PubTator, text mining | PubMed |
| Clinical and Genetic Analysis of 8 Children With Ornithine Transcarbamylase Deficiency: Two Novel Mutations. | Neurol Genet | 2024 | 39559585 | PubTator, text mining | PubMed |
| Interplay Between the Circadian Clock and Sirtuins. | Int J Mol Sci | 2024 | 39519022 | PubTator, text mining | PubMed |
| A 7T fMRI investigation of hand and tool areas in the lateral and ventral occipitotemporal cortex. | PLoS One | 2024 | 39499698 | PubTator, text mining | PubMed |
| A large-scale examination of inductive biases shaping high-level visual representation in brains and machines. | Nat Commun | 2024 | 39477923 | PubTator, text mining | PubMed |
| Perinatal management and follow-up in a child with a prenatal diagnosis of OTC deficiency: a case report. | Front Nutr | 2024 | 39403401 | PubTator, text mining | PubMed |
| In-depth analysis of OTC A208T case induced by OTC gene mutation and research on the prediction and simulation of the impact on protein function. | Front Pediatr | 2024 | 39328593 | PubTator, text mining | PubMed |
| Clinical characteristics and molecular genetic analysis of ten cases of ornithine carbamoyltransferase deficiency in southeastern China. | Ital J Pediatr | 2024 | 39256843 | PubTator, text mining | PubMed |
| Neonatal Presentation of Ornithine Transcarbamylase Deficiency Associated With a Hypomorphic OTC Variant (p.Leu301Phe) Previously Reported in Later-Onset Disease. | Cureus | 2024 | 39221296 | PubTator, text mining | PubMed |
| Proteo-metabolomics and patient tumor slice experiments point to amino acid centrality for rewired mitochondria in fibrolamellar carcinoma. | Cell Rep Med | 2024 | 39208801 | PubTator, text mining | PubMed |
| Unlocking the potential of soil microbial communities for bioremediation of emerging organic contaminants: omics-based approaches. | Microb Cell Fact | 2024 | 39054471 | PubTator, text mining | PubMed |
| Variant analysis and PGT-M of OTC gene in a Chinese family with ornithine carbamoyltransferase deficiency. | BMC Pregnancy Childbirth | 2024 | 39039447 | PubTator, text mining | PubMed |
| Genetically Modified Hepatocytes Targeting Bilirubin and Ammonia Metabolism for the Construction of Bioartificial Liver System. | Biomater Res | 2024 | 39011520 | PubTator, text mining | PubMed |
| Exploring the electronic structure of knotted proteins: the case of two ornithine transcarbamylase family. | J Mol Model | 2024 | 39008190 | PubTator, text mining | PubMed |
| Revisiting the Roles of Catalytic Residues in Human Ornithine Transcarbamylase. | Biochemistry | 2024 | 38940639 | PubTator, text mining | PubMed |
| Knot or not? Identifying unknotted proteins in knotted families with sequence-based Machine Learning model. | Protein Sci | 2024 | 38888487 | PubTator, text mining | PubMed |
| [Treatment of ornithine transcarbamylase deficiency in a child with glyceryl phenylbutyrate]. | Zhongguo Dang Dai Er Ke Za Zhi | 2024 | 38802913 | PubTator, text mining | PubMed |
| Efficient expansion and CRISPR-Cas9-mediated gene correction of patient-derived hepatocytes for treatment of inherited liver diseases. | Cell Stem Cell | 2024 | 38772378 | PubTator, text mining | PubMed |
| Proper network randomization is key to assessing social balance. | Sci Adv | 2024 | 38701217 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5009/papers?page=5